L-Argininamide,N-[4-[[4-(dimethylamino)phenyl]azo]benzoyl]-L-leucyl-L-alanyl-L-glutaminyl-L-alanyl-L-valyl-L-arginyl-L-seryl-L-seryl-L-seryl-N-[2-[(5-sulfo-1-naphthalenyl)amino]ethyl]-(9CI)
| Product Information | |
|---|---|
| Product Number: | AX-BI4J |
| Product Name: | L-Argininamide,N-[4-[[4-(dimethylamino)phenyl]azo]benzoyl]-L-leucyl-L-alanyl-L-glutaminyl-L-alanyl-L-valyl-L-arginyl-L-seryl-L-seryl-L-seryl-N-[2-[(5-sulfo-1-naphthalenyl)amino]ethyl]-(9CI) |
| CAS: | 396716-14-6 |
| MW: | 1573.78 |
| Synonyms: | ADAM-17 SUBSTRATE II, FLUOROGENIC;ADAM-17 SUBSTRATE III, FLUOROGENIC;DABCYL-TNF-ALPHA-EDANS (-4 TO +6) (HUMAN);DABCYL-TUMOR NECROSIS FACTOR-ALPHA-EDANS (-4 TO +6) (HUMAN);DABCYL-LAQAVRSSSR-EDANS;DABCYL-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-EDANS;TNF-ALPHA CONVERTASE ENZYME SUBSTRATE, FLUOROGENIC;TNF-ALPHA CONVERTASE ENZYME SUBSTRATE II, FLUOROGENIC |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |